Identifying and Preventing Soft Borer Disease

Saxitos, also known as lettuce, is rich in nutrients and is a low-sugar, low-fat vegetable that is popular with most people. As the market demand in Wenshan County has increased, the number of farmers who have cultivated lettuce has gradually increased. However, the occurrence of soft rot has been increasing year after year. The production and development of borage has been affected to a certain extent.

Vicia oleracea mainly damages the leaves, and stems and roots can also be damaged. The incidence of leaves begins with the leaf margin. It was watery at the beginning, browned later, softly rotted, and the leaves rotted. It is easy to attack at high temperatures in early autumn. The infected plants were wilted during the day and returned to normal in the early evening, but they could not recover in severe cases. Regarding the incidence of soft rot disease in Wenshan County, the County Plant Protection Station recommends that farmers adopt the following prevention and control measures:

1, the rotation, do not join with rape, celery.

2, the implementation of sorghum cultivation. Do a good job of fertilizer and water management, fertilization should avoid burning roots, irrigation should be uniform, prevent flooding.

3. Chemical prevention and control: 72% agricultural streptomycin 3000 times or 77% copper hydroxide 1000 times or 14% collaborative ammonia copper water spray should be used in time of onset.

Intermediates of Cladribine, Carvedilol, Lurasidone, olmesartan, Risedronate Sodium, Atazanavir, Saxagliptin, Dabigatran,Dapoxetine,Cefixime,Ceftaroline fosamil and etc.  

 

In the short span of time, we have emerged as most promising pharmaceutical intermediates manufacturers, chemical intermediates and bulk drug intermediates suppliers. Our consistent supply, quality products and dedication towards clients have opened up many international avenues for our growth.

 

In addition, the company also can follow the customer's product needs custom synthesis services

 

MAIN API  PRODUCTS   USP/BP

PRODUCT  NAME  

CAS NUMBER

SPEVIFICATION

Azithromycin

117772-70-0  

BEP

Cefpirome Sulphate sterile

84957-29-9     

USP JP16

Ceftriaxone Sodium (Sterile)

104376-79-6   

USP31

Cefotaxime     

64485-93-4  

USP30

Ciprofloxacin  HCL  

85721-33-1

USP/BP

Gentamicin sulphate  

1405-41-0  

BP

Levofloxacin  

100986-85-4  

USP27

Lincomycin   Hydrochloride  

859-18-7  

EP6.0

Moxifloxacin Hydrochloride  

186826-86-8  

USP31

Tigecycline

220620-09-7

USP

Linezolid

165800-03-3

EP

Dexamethasone   

50-02-2  

USP/BP/EP

Methylprednisolone

83-43-2  

USP/BP/EP

Dexketoprofen trometamol   

156604-79-4

BP2008

Ibuprofen

15687-27-1

BP

Metamizol

68-89-3

DAB

Sulindac  

38194-50-2   

USP/BP/EP

Naproxcinod   

163133-43-5

USP28

Tripelennamine Hydrochloride  

154-69-8   

USP28

Itraconazole  

84625-61-6   

USP/BP

Cytarabine

147-94-4     

USP31

Leucovorin Calcium

1492-18-8

USP32

Valsartan  

137862-53-4  

USP30

Telmisartan

144701-48-4  

USP31

Rosuvastatin Calcium   

147098-20-2

USP/BP

Pitavastatin Calcium

147526-32-7

USP/BP

Fluvastatin  

93957-54-1

USP31

Vinpocetine

42971-09-5  

EP6.0

Atazanavir  

198904-31-3

BP

Rosiglitazone

122320-73-4     

USP30

Esomeprazole Magnesium

161973-10-0

USP/BP

Topiramate   

 97240-79-4      

USP31

Fexofenadine HCl      

153439-40-8    

Inhouse

Bosentan    

147536-97-8    

Inhouse

D-Cysteine     

921-01-7      

Inhouse

D-Phenylalanine   

673-06-3  

Inhouse

Linagliptin                

668270-12-0  

Inhouse

Rivaroxaban

366789-02-8

USP

Saxagliptin   

361442-04-8      

USP

Vildagliptin      

274901-16-5       

USP

 

Major Pharmaceutical Intermediates

Items Descripation Structure Application
MICA ESTER
CAS No: 246035-38-1
Purity: ≥98%
246035-38-1 
For Cefixime
EHATA
CAS No: 64485-82-1
Purity: ≥98%
64485-82-1 
For Ceftazidine 
2-Chloroadenine
CAS No: 1839-18-5
 1839-18-5
 
For Cladribine, Fludarabine et al
Bicyclo(2,2,1)Heptane-2,3-di-exo-carboximide
CAS No: 14805o-29-9
14805o 29 9 
For Lurasidne
(R,R)-1,2-Bis(methanesulfonyloxy methyl)Cyclohexane
CAS No: 186204-35-3
186204-35-3
For Lurasidone
3-(Piperazin-1-yl)benzol[d] isothiazole
CAS No: 87691-87-0
87691 87 0 
For Lurasidone
Trityl olmesartan
CAS No: 144690-92-6
Purity: ≥98%

 144690-92-6
For olmesartan
3-Acetyl Pyridine
CAS No: 350-03-8

 350-03-8
For Risedronate Sodium 
3-(AceticAcid)pyridine HCL
CAS No: 6419-36-9
 6419-36-9
For Risedronate Sodium
Risedronic Acid
CAS No: 105462-24-6
105462-24-6 
For Risedronate Sodium
3-Hydroxy-1-adamantyl-D-Glycine
CAS No: 709031-29-8
 709031-29-8
For Saxagliptin
(1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3,1,0) hexane-2-carboxylic acid tert-butyl ester
CAS No: 361440-67-7
361440-67-7 
For Saxagliptin
(S)-N-Boc-3- hydroxy-adamantylglycine
CAS No: 361442-00-4
361442-00-4 
For Saxagliptin
2-Azabicyclo[3.1.0] hexane-3-carbonitrile, (1s,3s,5s)-
CAS No: 866083-42-3
 866083-42-3
For Saxagliptin
Ethyl 3-(pyridin-2-ylamino) propanoate
CAS No: 103041-38-9
103041-38-9 
For Dabigatran 
N-(4-Cyanophenyl) glycine
CAS No: 42288-26-6
42288-26-6 
For Dabigatran 
4-methylamino-3-nitrobenzoic Acid
CAS No: 41263-74-5
41263-74-5 
For Dabigatran 
S-3-Amino-3-phenylpropanoic acid ethyl ester HCL
CAS No: 167834-24-4
167834-24-4
 
For Dapoxetine
(S)-3-Amino-3-Phemylpropan -1-ol
CAS No: 82769-76-4

 82769-76-4
For Dapoxetine
(S)-3-Dimethylamino-3-Phemylpropanol
CAS No: 82769-75-3

82769-75-3 
For Dapoxetine
4-{4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butynil}-α,α-dimethyl benzene acetic acid
CAS No: 832088-68-3
  For Fexofenadine HCl
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate
CAS No:154477-54-0

154477-54-0 
For Fexofenadine HCl
5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone
CAS No 461432-22-4

461432 22 4 
For Dapagliflozin
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether
CAS No :461432-23-5

 461432 23 5
For Dapagliflozin

 

APIs & Intermediates

Mica Ester,Pharma Intermediates,Ciprofloxacin Hcl Uses,Active Pharmaceutical Ingredients

NINGBO VOICE BIOCHEMIC CO. LTD , https://www.pharma-voice.com